Ric Price

Menzies School of Health Research, Australia

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Infectious Diseases > Antimicrobials & Drug Resistance (since 19 April 2007)

All recent recommendations

• 3.0
  High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
  Recommended by Ric Price with Krispin Hajkowicz
  
• 6.0
  A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia.
  Recommended by Ric Price
  
• 4.8
  Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.
  Recommended by Ric Price, Johan Schoeman
  
• 3.0
  Quantitative dissection of clone-specific growth rates in cultured malaria parasites.
  Recommended by Ric Price
  
• 3.0
  Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
  Recommended by Ric Price
  
• 3.0
  Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
  Recommended by Ric Price
  
• 3.0
  Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.
  Recommended by Ric Price